Sutro Biopharma (STRO) Change in Account Payables (2017 - 2025)
Sutro Biopharma (STRO) posted Change in Account Payables of $575000.0 for Q4 2025, down 78.57% sequentially from $2.7 million in Q3 2025, and down 86.05% YoY from $4.1 million in Q4 2024.
Sutro Biopharma (STRO) Change in Account Payables (2017 - 2025) Analysis & Trends
Sutro Biopharma has reported Change in Account Payables for 9 years, with the latest figure at $575000.0 in Q4 2025.
- Quarterly Change in Account Payables fell 86.05% year-over-year to $575000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.5 million (down 449.58% YoY) and the FY2025 annual result came in at -$2.5 million, down 449.58% from the prior year.
- Change in Account Payables slipped to $575000.0 in Q4 2025 per STRO's latest filing, from $2.7 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.1 million in Q4 2024 and troughed at -$3.8 million in Q2 2025.
- A 5-year average of $226650.0 and a median of -$292500.0 in 2021 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables plunged 1058.08% in 2024, then surged 2281.3% in 2025.
- Over 5 years, Change in Account Payables stood at -$1.8 million in 2021, then surged by 47.24% to -$937000.0 in 2022, then surged by 532.98% to $4.1 million in 2023, then increased by 1.58% to $4.1 million in 2024, then plunged by 86.05% to $575000.0 in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered $575000.0, $2.7 million, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 575,000.00 |
| Dec 31, 2025 | 575,000.00 |
| Sep 30, 2025 | 2.68 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | -3.85 Mn |
| Jun 30, 2025 | -3.85 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | -123,000.00 |
| Sep 30, 2024 | -123,000.00 |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Sep 30, 2023 | 1.41 Mn |